Jubilant Pharmova Ltd. (JUBILANT LIFE SCIENCES )

In News

Jubilant Pharmova's Canada Plant Gets USFDA OAI Status, Remediation Underway - Medical Dialogues

Medical Dialogues - Feb 16, 2026

Jubilant Pharmova: Jubilant HollisterStier commissions new sterile injectable line in US facility - ET Manufacturing

ET Manufacturing - Oct 10, 2025

Jubilant Pharmova's Montreal Facility Completes USFDA Audit with 9 Observations - scanx.trade

scanx.trade - Nov 04, 2025

Jubilant Pharmova ropes in Daniel J O'Connor as CEO of Proprietary Novel drugs business - Medical Dialogues

Medical Dialogues - Dec 02, 2025

Jubilant Pharmova clears USFDA inspection with zero observations - CNBC TV18

CNBC TV18 - Sep 21, 2025

Why is Jubilant Pharmova share price buzzing in an overall weak market? - Business Standard

Business Standard - Jun 13, 2025

Jubilant Pharmova Names Arun Kumar Sharma as Chief Financial Officer - CXO Digitalpulse

CXO Digitalpulse - Sep 23, 2025

Jubilant Group Sells ₹1,801 Cr Stake in Block Deals - HDFC Sky

HDFC Sky - Jun 14, 2025

Pharma stock jumps 3% after launching new $132 million Sterile Fill & Finish line in US - Trade Brains

Trade Brains - Oct 10, 2025

Jubilant HollisterStier LLC launches New High-Speed Isolator based Line, at its Spokane Manufacturing Facility in the US - PR Newswire

PR Newswire - Oct 10, 2025

Jubilant Pharmova's US Subsidiary Aces USFDA Pharmacovigilance Inspection - scanx.trade

scanx.trade - Sep 20, 2025

USFDA issues 9 observations for Canada contract manufacturing facility: Jubilant Pharmova - Medical Dialogues

Medical Dialogues - Nov 05, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment